BaseSpace
Correlation Engine 2.0
Import Your Data
Literature

FAQ

More FAQs

Back to top
Clear Search sequence regions
(e.g. DRD2, nitric oxide metabolic process, Diabetes mellitus, Retina, Amniocentesis)
Bookmark Forward

What we have learned from the Xaliproden Sanofi-aventis trials.

P Douillet, J M Orgogozo

Sanofi-aventis, Montpellier, France.

The journal of nutrition, health & aging 2009 Apr


filter terms:
  • alzheimer disease (1)
  • biological markers (2)
  • humans (1)
  • magnetic resonance imaging (1)
  • naphthalenes (2)
  • pyridines (2)
  • randomized controlled trials as topic (1)
  • research design (1)
  • xaliproden (2)
    • Sizes of these terms reflect their relevance to your search.

    No abstract available.

    Citation

    P Douillet, J M Orgogozo. What we have learned from the Xaliproden Sanofi-aventis trials. The journal of nutrition, health & aging. 2009 Apr;13(4):365-6

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 19300882

    View Full Text
    • Copyright © 2021 Illumina Inc. All rights reserved.